None listed
Conditions
Interventions
None listed
Sponsors
Korea Centers for Disease Control and Prevention
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Age:18-40 2. Oligo or anovulation : menstrual cycle length in excess of 35 days or less than 8 cycles per year or absence of menstruation for more than 3 months 3. Clinical or biochemical hyperandrogenism : clinical HA (modified Ferriman-Gallwey score of more than 6) or biochemical HA (total testosterone >0.68 ng/mL or free T >1.72 pg/mL or free androgen index >5.36) 4.Polycystic on ultrasound : 12 or more follicles measuring 2-9 mm in diameter in each ovary and/or enlarged ovarian volume(10?)
Exclusion criteria
Exclusion criteria: 1. Exclusion of related disorders such as ovarian deficiency symptom, Hypothyroidism, Hyperprolactinemia, Congenital adrenal hyperplasia 2. Subjects who refuse to participate in this study 3. Subjects with use or oral contraceptives in the previous 1 month
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hypertension ;Dyslipidemia;insulin resistance ;Impaired glucose tolerance ;Metabolic syndrome;Obesity | — |
Secondary
| Measure | Time frame |
|---|---|
| Cardiovascular disease risk factor | — |
Countries
Korea, Republic of
Contacts
Public ContactJin-Ju Kim
Seoul National University Healthcare System Gangnam Center
Outcome results
None listed